drugset / Trial / NCT07792408
Effects of VX-407 on the Pharmacokinetics of Combined Oral Contraceptives
Non-randomizedSequentialOpen-labelTreatment
Summary
The purpose of the study is to evaluate the pharmacokinetic effects and safety and tolerability of VX-407 when coadministered with oral contraceptives.
Timeline
- Start
- 2026-09-01
- Primary completion
- 2027-03-11
- Completion
- 2027-03-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Levonorgestrel | Small molecule | — | Oral |
| Subject | Norethindrone | Unknown | — | Oral |
| Subject | Norgestimate | Small molecule | — | Oral |
| Subject | VX-407 | Unknown | — | Oral |
| Subject | drospirenone | Unknown | — | Oral |
| Subject | ethinyl estradiol | Small molecule | — | Oral |